Biolegio

Company Snapshot

Founded: 1996
Entity Type: Private
Region: The Netherlands
Headquarter: The Netherlands
Key Geographics: Europe
Corporate Address: PO Box 91 6500 AB Nijmegen The Netherlands Tel. +31-(0)24-358-6885 www.biolegio.com

Company Overview

Biolegio B.V. was founded in 1996. Simple custom-made DNA oligos have given way to highly modified and specialized oligos for a wide range of life science applications in the company's product line over the years. Sequencing and NGS, PCR, Real-Time PCR, SNP detection, genotyping, gene expression, and mutation detection are some of these applications. In order to meet the demands for clinical and molecular diagnostic products, the company offers its whole product portfolio, which ranges from small-scale synthesis for R&D to high scale/bulk OEM and B2B services for production requirements. All products are manufactured to the highest quality standards and are traceable.

The company has a manufacturing site located on the campus of the Radboud University in Nijmegen, which it recently expanded. Biolegio B.V. delivers its products through distributors in countries such as Australia, Israel, Lithuania, Greece, Ecuador, Spain, Tunis and Sweden. The company has collaborated with Synthego on a genome editing portfolio for CRISPR applications.

Biolegio In Reports

Oligonucleotides: Global Markets

BCC Research Market Analyst says global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028 at a CAGR of 11.0%.

Oligonucleotides: Global Markets to 2026

BCC Research Market Report says oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a CAGR of 10.7%

Company's Business Segments

  • Life Science and Molecular Diagnostics : The company offers custom oligonucleotide solutions for life science applications and molecular diagnostics.

Applications/End User Industries

  • Healthcare
  • Molecular Diagnostics
  • Life Sciences
AI Sentiment